FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

1233160 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
Acetaminophen 100 mg/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 100 mg/mL oral suspension Acceptable (foundation metadata concept)
Acetaminophen 1000mg/100mL infusion solution (product) Preferred (foundation metadata concept)
Acetaminophen 10mg/mL injection solution 50mL vial (product) Preferred (foundation metadata concept)
Acetaminophen 120 mg rectal suppository Acceptable (foundation metadata concept)
Acetaminophen 120 mg/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 120mg paediatric soluble tablet Acceptable (foundation metadata concept)
Acetaminophen 120mg suppository (product) Preferred (foundation metadata concept)
Acetaminophen 120mg/5mL oral suspension sachet (product) Preferred (foundation metadata concept)
Acetaminophen 120mg/5mL s/f oral solution Acceptable (foundation metadata concept)
Acetaminophen 120mg/5mL s/f oral suspension Acceptable (foundation metadata concept)
Acetaminophen 120mg/5mL s/f oral suspension sachet (product) Preferred (foundation metadata concept)
Acetaminophen 125 mg rectal suppository Acceptable (foundation metadata concept)
Acetaminophen 125mg suppository (product) Preferred (foundation metadata concept)
Acetaminophen 150 mg and sodium salicylate 100 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 16 mg/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 160 mg chewable tablet Acceptable (foundation metadata concept)
Acetaminophen 160 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 160 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 160mg/5mL elixir (product) Preferred (foundation metadata concept)
Acetaminophen 160mg/5mL liquid (product) Preferred (foundation metadata concept)
Acetaminophen 1g/sachet powder (product) Preferred (foundation metadata concept)
Acetaminophen 21.7 mg/mL and hydrocodone bitartrate 500 microgram/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 24 mg/mL and promethazine hydrochloride 300 microgram/mL oral suspension Acceptable (foundation metadata concept)
Acetaminophen 24 mg/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 24 mg/mL oral suspension Acceptable (foundation metadata concept)
Acetaminophen 240 mg rectal suppository Acceptable (foundation metadata concept)
Acetaminophen 25 mg/mL and ibuprofen 20 mg/mL oral suspension Acceptable (foundation metadata concept)
Acetaminophen 250 mg and aspirin 250 mg and caffeine 65 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 250 mg and salicylamide 600 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 250 mg orodispersible tablet Acceptable (foundation metadata concept)
Acetaminophen 250 mg rectal suppository Acceptable (foundation metadata concept)
Acetaminophen 250mg oro-dispersible tablet (product) Preferred (foundation metadata concept)
Acetaminophen 250mg/5mL s/f oral suspension Acceptable (foundation metadata concept)
Acetaminophen 300 mg and codeine phosphate 15 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and codeine phosphate 30 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and codeine phosphate 60 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and hydrocodone bitartrate 10 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and oxycodone hydrochloride 10 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and oxycodone hydrochloride 2.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and oxycodone hydrochloride 5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and oxycodone hydrochloride 7.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 300 mg rectal suppository Acceptable (foundation metadata concept)
Acetaminophen 32 mg/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and butalbital 50 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 325 mg and butalbital 50 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and caffeine 100 mg and isometheptene mucate 65 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 325 mg and dichloralphenazone 100 mg and isometheptene 65 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 325 mg and hydrocodone bitartrate 10 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and hydrocodone bitartrate 2.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and hydrocodone bitartrate 5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and hydrocodone bitartrate 7.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and isometheptene mucate 65 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 325 mg and oxycodone hydrochloride 10 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and oxycodone hydrochloride 2.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and oxycodone hydrochloride 7.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and propoxyphene 32.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and propoxyphene hydrochloride 32.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and propoxyphene napsylate 100 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and propoxyphene napsylate 50 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg and tramadol 37.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 325 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 325 mg rectal suppository Acceptable (foundation metadata concept)
Acetaminophen 325mg/hydrocodone 10mg 15mL oral solution (product) Preferred (foundation metadata concept)
Acetaminophen 325mg/hydrocodone 7.5mg 15mL oral solution (product) Preferred (foundation metadata concept)
Acetaminophen 33.3 mg/mL and hydrocodone bitartrate 333 microgram/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 33.3 mg/mL and hydrocodone bitartrate 500 microgram/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 356.4 mg and caffeine 30 mg and dihydrocodeine tartrate 16 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 400 mg and hydrocodone bitartrate 10 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 400 mg and hydrocodone bitartrate 5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 400 mg and hydrocodone bitartrate 7.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 400 mg and oxycodone hydrochloride 7.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 450 mg and caffeine 25 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 450 mg and caffeine 30 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 48.2 mg/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 5 mg/mL and caffeine 650 microgram/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 50 mg/mL oral solution Acceptable (foundation metadata concept)
Acetaminophen 50 mg/mL oral suspension Acceptable (foundation metadata concept)
Acetaminophen 500 mg and butalbital 50 mg and caffeine 40 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 500 mg and butalbital 50 mg and caffeine 40 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and caffeine 65 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and clemastine fumarate 335 microgram and phenylpropanolamine 30 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 12.8 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 13.5 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 15 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 30 mg effervescent oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 30 mg effervescent powder for oral suspension sachet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 30 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 30 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 8 mg effervescent oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 8 mg oral capsule Acceptable (foundation metadata concept)
Acetaminophen 500 mg and codeine phosphate 8 mg oral tablet Acceptable (foundation metadata concept)
Acetaminophen 500 mg and dihydrocodeine tartrate 10 mg oral tablet Acceptable (foundation metadata concept)

Start Previous Page 360 of 12332 Next End

Reference Sets

Reference set descriptor

Back to Start